Success Metrics

Clinical Success Rate
83.3%

Based on 5 completed trials

Completion Rate
83%(5/6)
Active Trials
0(0%)
Results Posted
40%(2 trials)
Terminated
1(17%)

Phase Distribution

Ph not_applicable
1
17%
Ph phase_3
1
17%
Ph phase_4
3
50%
Ph phase_1
1
17%

Phase Distribution

1

Early Stage

0

Mid Stage

4

Late Stage

Phase Distribution6 total trials
Phase 1Safety & dosage
1(16.7%)
Phase 3Large-scale testing
1(16.7%)
Phase 4Post-market surveillance
3(50.0%)
N/ANon-phased studies
1(16.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

83.3%

5 of 6 finished

Non-Completion Rate

16.7%

1 ended early

Currently Active

0

trials recruiting

Total Trials

6

all time

Status Distribution
Completed(5)
Terminated(1)

Detailed Status

Completed5
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
6
Active
0
Success Rate
83.3%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (16.7%)
Phase 31 (16.7%)
Phase 43 (50.0%)
N/A1 (16.7%)

Trials by Status

completed583%
terminated117%

Recent Activity

0 active trials
Showing 5 of 6
completedphase_4

13-C Urea Breath Test Using BreathID System and PPIs (Proton Pump Inhibitors)

NCT00825630
terminatednot_applicable

Evaluation of Esomeprazole in Treating Gastro-esophageal Reflux Disease (GERD) in Head and Neck Cancer Patients Exposed to Radiation Therapy

NCT00222079
completedphase_4

Nexium (Esomeprazole) in Symptom Adapted Therapy in GERD Patients

NCT00444275
completedphase_1

Study Comparing Esomeprazole and Acetylsalicylic Acid (ASA) Combined Together as One Capsule Versus These Medications Taken Separately

NCT00998075
completedphase_3

Safety of Daily Dose Esomeprazole for GERD for Pediatric and Adolescent Patients

NCT00241501
View all 6 trials

Clinical Trials (6)

Showing 6 of 6 trials
NCT00825630Phase 4

13-C Urea Breath Test Using BreathID System and PPIs (Proton Pump Inhibitors)

Completed
NCT00222079Not Applicable

Evaluation of Esomeprazole in Treating Gastro-esophageal Reflux Disease (GERD) in Head and Neck Cancer Patients Exposed to Radiation Therapy

Terminated
NCT00444275Phase 4

Nexium (Esomeprazole) in Symptom Adapted Therapy in GERD Patients

Completed
NCT00998075Phase 1

Study Comparing Esomeprazole and Acetylsalicylic Acid (ASA) Combined Together as One Capsule Versus These Medications Taken Separately

Completed
NCT00241501Phase 3

Safety of Daily Dose Esomeprazole for GERD for Pediatric and Adolescent Patients

Completed
NCT00228527Phase 4

Esomeprazole for Treatment of GERD in Pediatric Patients

Completed

All 6 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
6